Article
Quantitative live imaging of cancer and normal cells treated with Kinesin-5 inhibitors indicates significant differences in phenotypic responses and cell fate.
Molecular cancer therapeutics - 1 Nov 2008
Orth James D, Tang Yangzhong, Shi Jade, Loy Clement T, Amendt Christiane, Wilm Claudia, Zenke Frank T, Mitchison Timothy J
Abstract excerpt
Kinesin-5 inhibitors (K5I) are promising antimitotic cancer drug candidates. They cause prolonged mitotic arrest and death of cancer cells, but their full range of phenotypic effects in different cell types has been unclear. Using time-lapse microscopy of cancer and normal cell lines, we find that a novel K5I causes several different cancer and noncancer cell types to undergo prolonged arrest in monopolar...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
